Back to Search Start Over

Folfoxiri plus Bevacizumab as first-line treatment of BRAF mutant metastatic colorectal cancer patients

Details

Language :
English
Database :
OpenAIRE
Journal :
Università di Pisa-IRIS, ResearcherID
Accession number :
edsair.dedup.wf.001..252af403d588f3660d82d7f74b6a5a82